SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer
about
From sirtuin biology to human diseases: an updateModulation of tumorigenesis by dietary intervention is not mediated by SIRT1 catalytic activityResveratrol modulates the inflammatory response via an estrogen receptor-signal integration networkEmerging Roles of SIRT1 in Cancer Drug ResistanceHistone/protein deacetylase SIRT1 is an anticancer therapeutic target.Age-associated changes in oxidative stress and NAD+ metabolism in human tissue.The many faces of estrogen signaling.High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.Regulation of SIRT1 in vascular smooth muscle cells from streptozotocin-diabetic ratsSIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancer.2-Hydroxyestradiol slows progression of experimental polycystic kidney diseaseIdentification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancerSIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasionDietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.Enhancement of NAD⁺-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells.SIRT1 positively regulates breast cancer associated human aromatase (CYP19A1) expression.The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene ExpressionThe plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function.Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activitySIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells.Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets.The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinomaExpression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer.MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1.SIRT1 promotes the proliferation and metastasis of human pancreatic cancer cells.Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target.Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.Targeted Protein Degradation by Small Molecules.Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2).MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1.Estrogens regulate life and death in mitochondria.Histone deacetylase III as a potential therapeutic target for the treatment of lethal sepsisSIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells.SIRT1 Enhances the Survival of Human Embryonic Stem Cells by Promoting DNA Repair.Differential effect of estradiol and bisphenol A on Set8 and Sirt1 expression in prostate cancer.Excessive levels of diverse phytoestrogens can modulate steroidogenesis and cell migration of KGN human granulosa-derived tumor cells.
P2860
Q27022606-2D796ADE-2BF0-41B8-89E2-EFB7FAB081A4Q27330338-ED7AD591-9980-4A7D-94F0-EF39566C5A2BQ27683572-223F75AF-180F-4E44-88FA-47FA9B21780BQ28536892-FD99825E-C8D7-43A5-AA82-DE762444FCEBQ33785586-FB635F99-03FF-4D66-8A78-D058C6EBF164Q34359729-C7857D05-3666-4FF5-B93D-D979A30ED97CQ34408630-D02BEB92-5E44-43D3-89B8-23E90DB5618EQ34698817-7A5DB978-170B-4A69-9165-0F637F976E0CQ34756058-E5A928DA-CA6C-4E39-BCE7-1C93ED577741Q35054129-DB31A031-2D44-48D7-9BCD-86BF4C6148F5Q35964504-9A2DEF73-6413-4E82-BF30-7E8D7C34FE50Q36031493-0DBA4BED-FDFF-46AB-A195-DBBECE826BD4Q36293908-BD808C09-F7D8-47CA-8917-E2885D16F74CQ36413835-18AE93D2-1C91-4646-B518-E9619EE31870Q36460483-5ECD94F2-489D-4D56-90C6-0F3662E75491Q36508254-C2B5DE55-2CA7-400F-B6B1-BB7A9B814CEDQ36619057-BA81852D-290F-4645-81EF-4D976138E06EQ36660569-0700369D-4691-4988-9141-408D97581B94Q36745136-1B83B18B-DE18-44D8-ADB5-F7C0ACB28844Q37009435-59449EE6-5B15-43CF-A61F-5BC72493D37EQ37350626-1164A674-FA13-4143-B20F-E52E05793CFFQ37367256-C6D2C12B-A58B-4DDE-9939-BD04521ACBB9Q37527738-208648AF-6C27-492C-857A-6B3D5E7272D1Q37621301-3807B0B9-802D-4976-BC6D-46F127100FECQ37708962-F6BAAFB4-C6CD-4CEA-A276-472B491F39BBQ38423284-CC0AE176-7DC7-4CA1-85EB-49C078A1430CQ38638014-069921A6-7176-4EBB-B361-5C66784D1B91Q38709889-A7E909DF-E6AC-4F1C-90B8-408AAB67E0A2Q38835509-16EEA5DE-5F8F-4F52-8830-00E844E1A690Q38881949-C4D97C19-38EA-443D-AE3A-DB7632CA66F1Q38978952-39BAE3BB-6A78-44D1-B525-81F07C574FE6Q39022839-8523A6A5-1818-467B-BAA3-7E0D50F37BAEQ39026925-903262EB-E5B1-446A-A04A-84A1972D0074Q39121751-5393A2D9-5A30-4548-8C33-B3F248902E3CQ39236899-B210D37C-E9A4-4755-BD1F-02DEF6716908Q39955711-0D7702BF-26B8-4643-AC19-4450F9F62487Q40999646-B05D5588-63A5-4075-83B1-35AE11840328Q41324259-F56027F0-00FF-45C8-82D5-EE1CD7D8029AQ41680469-453C13A4-E620-42BD-B4C1-B9AD591EF6BCQ41681370-287B1FBF-63B7-4711-84EF-5E1BBF2D7E4E
P2860
SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
SIRT1 is essential for oncogen ...... en receptor α in breast cancer
@ast
SIRT1 is essential for oncogen ...... en receptor α in breast cancer
@en
type
label
SIRT1 is essential for oncogen ...... en receptor α in breast cancer
@ast
SIRT1 is essential for oncogen ...... en receptor α in breast cancer
@en
prefLabel
SIRT1 is essential for oncogen ...... en receptor α in breast cancer
@ast
SIRT1 is essential for oncogen ...... en receptor α in breast cancer
@en
P2093
P2860
P1433
P1476
SIRT1 is essential for oncogen ...... en receptor α in breast cancer
@en
P2093
Darren D Browning
Jaya P Gnana-Prakasam
Muthusamy Thangaraju
Narayanan Venkatesan
Pamela M Martin
Patricia V Schoenlein
Puttur D Prasad
Sabarish Ramachandran
Selvakumar Elangovan
Sudha Ananth
P2860
P304
P356
10.1158/0008-5472.CAN-11-1446
P407
P577
2011-09-15T00:00:00Z